论文信息 - National Survey on Clinical Practice of Gene Therapy using Adeno-associated Virus Vector ―The Actual Status and Hurdle on Clinical Practice in Gene Therapy for Spinal Muscular Atrophy― - 字舞流文

National Survey on Clinical Practice of Gene Therapy using Adeno-associated Virus Vector ―The Actual Status and Hurdle on Clinical Practice in Gene Therapy for Spinal Muscular Atrophy―

M. Onodera | Masayoshi Nakakuni

[1] Y. Maruyama,et al. Current status and future perspective of gene therapy products in Japan , 2021 .

[2] J. K. Hennigs,et al. Inactivation of Adeno-Associated Viral Vectors by Oxidant-Based Disinfectants. , 2020, Human gene therapy.

[3] A. Srivastava,et al. Hemophilia gene therapy knowledge and perceptions: Results of an international survey , 2020, Research and practice in thrombosis and haemostasis.

[4] J. Mendell,et al. From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1. , 2019, Pediatric neurology.

[5] A. Tamaoka,et al. Infectivity assessment of recombinant adeno-associated virus (rAAV) and wild-type AAV (wtAAV) exposed to various diluents and environmental conditions. , 2019, Human gene therapy methods.

[6] Michael A Storey,et al. Gene Replacement Therapy: A Primer for the Health-system Pharmacist , 2019, Journal of pharmacy practice.

[7] K. Campbell,et al. Viral-mediated gene therapy and genetically modified therapeutics: A primer on biosafety handling for the health-system pharmacist. , 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8] I. Alexander,et al. Gene therapy clinical trials worldwide to 2017: An update , 2018, The journal of gene medicine.